Literature DB >> 12609012

Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias.

Guido Grassi1, Gino Seravalle, Giovanni Bertinieri, Giuseppe Mancia.   

Abstract

AIM: Animal studies have conclusively shown that the sympathetic nervous system plays a major role not only in regulating sinus node activity but also in promoting cardiac rhythm alterations. Less univocal and often circumstantial have been the evidences collected on this issue in humans. However, the introduction of the microneurographic technique in clinical research has allowed to gain new important insights on the role of neuroadrenergic factors in the pathophysiology of cardiac arrhythmias.
METHODS: The present paper will review the results of microneurographic studies performed by our group and others in the field of cardiac rhythm disturbances by addressing three specific issues. First it will examine the relationships between heart rate and muscle sympathetic neural outflow in a variety of cardiovascular diseases characterized by sympathetic activation. This will be followed by an analysis of the behaviour of the sympathetic nerve traffic responses to paroxysmal atrial fibrillation. Finally, the sympathetic adjustments to spontaneously occurring or artificially induced pre-mature ventricular contractions will be highlighted.

Entities:  

Mesh:

Year:  2003        PMID: 12609012     DOI: 10.1046/j.1365-201X.2003.01092.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

1.  Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation.

Authors:  Tatsunori Ikeda; Hisayoshi Murai; Shuichi Kaneko; Soichiro Usui; Daisuke Kobayashi; Manabu Nakano; Keiko Ikeda; Shin-Ichiro Takashima; Takeshi Kato; Masaki Okajima; Hiroshi Furusho; Masayuki Takamura
Journal:  J Physiol       Date:  2011-12-05       Impact factor: 5.182

2.  Prognostic significance of PVCs and resting heart rate.

Authors:  Gregory Engel; Shaun Cho; Afshin Ghayoumi; Takuya Yamazaki; Sung Chun; William F Fearon; Victor F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

3.  Sympathetic responses induced by radiofrequency catheter ablation of atrial fibrillation.

Authors:  Jian Cui; Mario D Gonzalez; Cheryl Blaha; Ashley Hill; Lawrence I Sinoway
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-07       Impact factor: 4.733

Review 4.  Catheter Ablation of Atrial Fibrillation in Overweight and Obese Patients.

Authors:  Louiza Lioni; Panagiotis Korantzopoulos; Konstantinos P Letsas
Journal:  J Atr Fibrillation       Date:  2011-12-20

Review 5.  Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.

Authors:  Gino Seravalle; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-05-01

Review 6.  Sympathetic mechanisms, organ damage, and antihypertensive treatment.

Authors:  Guido Grassi; Gino Seravalle; Raffaella Dell'Oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

7.  Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.

Authors:  Eckhard Schwertfeger; Thomas Klein; Oliver Vonend; Vitus Oberhauser; Johannes Stegbauer; Lars Christian Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-22       Impact factor: 3.000

8.  Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function.

Authors:  Thomas Bitter; Christoph Langer; Jürgen Vogt; Mathias Lange; Dieter Horstkotte; Olaf Oldenburg
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

9.  Advantage of recording single-unit muscle sympathetic nerve activity in heart failure.

Authors:  Hisayoshi Murai; Masayuki Takamura; Shuichi Kaneko
Journal:  Front Physiol       Date:  2012-05-03       Impact factor: 4.566

Review 10.  Type D Personality as a Risk Factor in Coronary Heart Disease: a Review of Current Evidence.

Authors:  Nina Kupper; Johan Denollet
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.